19 June 2013
Keywords: medeva, hep, vaccine, protective, therapeutic, uk, reported
Article | 16 October 1997
Medeva of the UK has reported new clinical data which give furtherevidence that its third-generation hepatitis B vaccine Hepagene is
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 October 1997
23 October 1997
© 2013 thepharmaletter.com